Novo Nordisk A/S
NOVO B
Company Profile
Business description
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Contact
Novo Alle 1
Bagsvaerd 2880
DNKT: +45 44448888
E: phak@novonordisk.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
66,015
Novo Nordisk A/S News & Analysis
funds
Wirecard scandal: Should fund managers bet big?
Fund managers are urged to have the courage of their convictions, but the scandal around the German payments provider shows how that approach can go wrong.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,991.30 | 85.40 | -1.06% |
| CAC 40 | 8,131.41 | 55.73 | 0.69% |
| DAX 40 | 18,498.38 | 68.33 | 0.37% |
| Dow JONES (US) | 39,056.39 | 172.13 | 0.44% |
| FTSE 100 | 8,354.05 | 40.38 | 0.49% |
| HKSE | 18,538.57 | 224.71 | 1.23% |
| NASDAQ | 16,302.76 | 29.80 | -0.18% |
| Nikkei 225 | 38,294.79 | 92.42 | 0.24% |
| NZX 50 Index | 11,712.64 | 70.25 | -0.60% |
| S&P 500 | 5,187.67 | 0.03 | -0.00% |
| S&P/ASX 200 | 7,718.20 | 86.30 | -1.11% |
| SSE Composite Index | 3,156.96 | 28.48 | 0.91% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.04 | 0.00 | 6.76% |
| Imugene Ltd IMU | 0.07 | 0.00 | -5.33% |
| Vicinity Centres VCX | 1.94 | 0.01 | -0.26% |
| Strike Energy Ltd STX | 0.24 | 0.02 | 6.82% |
| Pilbara Minerals Ltd PLS | 4.13 | 0.06 | -1.32% |
| Westpac Banking Corp WBC | 26.33 | 1.56 | -5.59% |
| Liontown Resources Ltd LTR | 1.38 | 0.05 | 3.38% |
| Mesoblast Ltd MSB | 1.11 | 0.02 | -1.99% |
| Telstra Group Ltd TLS | 3.63 | 0.03 | -0.68% |
| Sigma Healthcare Ltd SIG | 1.30 | 0.00 | 0.00% |